(Q35579736)

9 August 2017

1 reference

title

Psychiatric issues in older cancer patients (English)

1 reference

9 August 2017

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

30 March 2024

author name string

Reena Modi

2

1 reference

9 August 2017

Andrew J. Roth

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607382

30 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14607382

30 March 2024

publication date

1 November 2003

1 reference

full work available at URL

9 August 2017

https://api.elsevier.com/content/article/PII:S1040842803002099?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

https://api.elsevier.com/content/article/PII:S1040842803002099?httpAccept=text/plain

30 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Critical Reviews in Oncology Hematology

30 March 2024

published in

1 reference

9 August 2017

48

1 reference

9 August 2017

2

1 reference

9 August 2017

185-197

1 reference

Course of depression in patients with hypertension, myocardial infarction, or insulin-dependent diabetes

9 August 2017

3

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Oncology staff recognition of depressive symptoms on videotaped interviews of depressed cancer patients: implications for designing a training program.

30 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Physical functioning and depression among older persons with cancer

30 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Cross-cultural comparison of depression and depressive symptoms in older people

30 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study.

30 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Development and validation of a geriatric depression screening scale: a preliminary report

30 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

The hospital anxiety and depression scale

30 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

30 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Screening for depression in elderly primary care patients. A comparison of the Center for Epidemiologic Studies-Depression Scale and the Geriatric Depression Scale.

30 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Depression in hospitalized cancer patients

30 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Depression in Medical In-Patients

30 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Diagnosing depression in medical inpatients

30 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms

30 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Depression and the cancer patient

30 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Psychopathology of pancreatic cancer. A psychobiologic probe

30 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Effect of psychosocial treatment on survival of patients with metastatic breast cancer

30 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later

30 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses

30 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Antidepressants and cancer: cause for concern?

30 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Concern over Prozac-induced tumor growth may dwindle following FDA study

30 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Pharmacological principles of antidepressant efficacy

30 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Explicit criteria for determining potentially inappropriate medication use by the elderly. An update

30 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Inappropriate medication prescribing in homebound older adults

30 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Inappropriate prescribing for the elderly: beers criteria-based review

30 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Possible medication errors in home healthcare patients

30 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Inappropriate Prescribing Before and After Nursing Home Admission

30 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence

30 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Psychostimulants for depression in hospitalized cancer patients.

30 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Use of stimulants in the medically ill.

30 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Dextroamphetamine treatment for depression in terminally ill patients

30 March 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Cognitive impairment due to AIDS-related complex and its response to psychostimulants

30 March 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Pemoline. An alternative psychostimulant for the management of depressive disorders in cancer patients

30 March 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

The cognitive effects of the administration of narcotic analgesics in patients with cancer pain.

30 March 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer

30 March 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Mirtazapine may be useful in treating nausea and insomnia of cancer chemotherapy

30 March 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Paroxetine for the prevention of depression induced by high-dose interferon alfa

30 March 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Phase III evaluation of fluoxetine for treatment of hot flashes

30 March 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer.

30 March 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial

30 March 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Anxiety symptoms and panic attacks preceding pancreatic cancer diagnosis.

30 March 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Delirium in terminally ill cancer patients

30 March 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients

30 March 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Corticosteroids in cancer: neuropsychiatric complications

30 March 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells.

30 March 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

30 March 2024

Drug-induced depression

55

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Neuropsychiatric toxicity associated with cytokine therapies

30 March 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

30 March 2024

“Mini-mental state”

59

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Common psychiatric disorders in cancer patients. II. Anxiety and acute confusional states

30 March 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Delirium in Cancer Patients

30 March 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Usage of haloperidol for delirium in cancer patients

30 March 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients

30 March 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

Olanzapine in the treatment of delirium

30 March 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients

30 March 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.CRITREVONC.2003.06.004

30 March 2024

Identifiers

1 reference

9 August 2017

1 reference